Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
|Articles|October 2, 2021
- Pharmaceutical Technology, October 2021 Issue
- Volume 45
- Issue 10
Small Bore Tubing Connectors
Colder Products Company MicroCNX Series Connectors provide an alternative to tube welding for small-volume, closed aseptic processes.
MicroCNX connectors are specifically designed for small-volume processes involving 1/16 in. (1.6 mm), 3/32 in. (2.4 mm), and 1/8 in. (3.2 mm) small-bore tubing. The connectors can be incorporated into pre-made tubing assemblies.
To use the aseptic connector, users must pinch to remove the protective cover, click together the connector halves, and pull out the protective membranes to allow flow to begin. This process is intended to be a simpler solution to traditional tube welding, which requires maneuvering the tube welder into position, equipment maintenance, and precise technique.
Articles in this issue
about 5 years ago
Automating Aseptic Manufacturingabout 5 years ago
Considering Bio/Pharma Reformulation Strategiesabout 5 years ago
Pharma Sets a Foundation for Greener API Manufacturingabout 5 years ago
Adopting Continuous Manufacturing for Solid-Dose Drug Productsabout 5 years ago
Determining Shelf Life: Reading the Stability Testing Dataabout 5 years ago
Trends Affecting Biopharmaceutical Manufacturingabout 5 years ago
European Pharmacopoeia Updates: EDQM Tackles Nitrosamine Impuritiesabout 5 years ago
Public Trust in Medicine Quality as Public Health Challenges Emergeabout 5 years ago
FDA Moves to Advance Innovative ExcipientsRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
FDA approved pimicotinib for TGCT based on a 56% response rate; its Project Orbis review signals tighter global launch planning for manufacturers.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5